Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
652,092
-
Share change
-
+37,469
-
Total reported value
-
$143,343,779
-
Price per share
-
$219.89
-
Number of holders
-
7
-
Value change
-
+$8,235,029
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2023
As of 31 Dec 2023 UNITED THERAPEUTICS Corp - Common Stock (UTHR) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 652,092 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 527 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.